Acumen Pharmaceuticals, Inc. (ABOS) vs Canton Strategic Holdings Inc (CNTN)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Canton Strategic Holdings Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.04HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
CNTN
Canton Strategic Holdings Inc
$2.37HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ABOS vs CNTN
growth of $100 · dividends reinvested · last 5yABOS -62.2% (-17.7%/yr)CNTN -99.8% (-71.8%/yr)ABOS compounded faster over this window
Log scale — wide-divergence pair
ABOS CNTN
ABOS vs CNTN: by the numbers
- •CNTN is the larger company ($182M vs $147M market cap).
- •Both run net losses; ABOS's is the smaller (0.00% vs -6559.27% net margin).
Metrics side by side
Valuation
| Metric | ABOS | CNTN |
|---|---|---|
| P/S ratio | N/A | 121.93 |
| P/B ratio | 2.57 | 0.40 |
Profitability
| Metric | ABOS | CNTN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -6559.27% |
| ROE | -183.44% | -21.57% |
| ROIC | -118.67% | -9.57% |
Growth (annualized)
| Metric | ABOS | CNTN |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.